Psychedelic Policy Briefing 8.21.26
Resilient Pharmaceuticals (formerly Lykos Therapeutics and MAPS PBC), reportedly resubmitted their once-rejected New Drug Application (NDA) for MDMA-assisted therapy for PTSD to the FDA, triggering a fresh review cycle under the agency's newly finalized psychedelic clinical trial guidance. The post Psychedelic Policy Briefing 8.21.26 first appeared on Lucid News.
External link. We are not responsible for the content.
Read more ↗More From Lucid News
Weekly Psychedelic Policy Briefing – August 14, 2026
The FDA has finalized guidance on clinical investigations into psychedelic-assisted therapies and contract research o...
Psychedelic Policy Briefing
In this week's psychedelic policy briefing, investigative journalist Jack Gorsline unpacks a wave of state and federa...
Have You Had Difficulties After a Trip? The Emory Center for Psychedelics and Spirituality Wants to Hear From You
An international research consortium including Brown University, the University of Melbourne, the University of North...
Latest News
What’s stopping psychedelic therapy in China? 5 Questions with medical ethicist Jennifer Docherty
Docherty discusses her interviews about psychedelic end-of-life care with clinicians in Hong Kong.
MDMA and the FDA, Take Two
PLUS the Psychedelic Seeker's Guide, the World Ayahuasca Forum, and the best films to get trippy to. [...] Read More....
Global Altered States: Anytown, USA
This Week's Sunday Insider, Global Altered States: The Psychedelic Revolution is smaller than it looks.
What is an “embedded” brain? Johnson & Johnson plans to invest in “neuroplastogen” company Delix; and University of Miami gifts Trump Administration accelerated path to research ibogaine
Plus: Oregon psilocybin program “generally safe,” according to new study, and New Mexico begins accepting psilocybin ...
5 Psychedelic Stories You Should Know This Week
Welcome to The Psychedelic Blog. Bestselling essayist & Psychedelic cultural analyst examining how altered states sha...
Orchidaceaen Ethics 1
On acid, ancient philosophy, and the problem of knowing